Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
GHK Capital Partners acquisition of Hasa and related financing
Davis Polk advised GHK Capital Partners LP on its acquisition of Hasa, Inc. and the related financing arrangements. Davis…
Energizer Holdings $600 million senior notes offering and cash tender offer
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by…
Spectrum Brands $300 million notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A and Regulation S…
Xylem $1 billion inaugural green notes offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Xylem Inc. of $500…
Schlumberger $900 million notes offering and concurrent tender offer
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Schlumberger Investment SA of …
Livent $225 million green convertible senior notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Livent…
Niagara Mohawk Power notes offerings, including first $600 million green notes
Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $600…
Abbott Laboratories $1.3 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million…
Seagate HDD Cayman $500 million exchange offers
Davis Polk advised the lead dealer managers in connection with the Rule 144A/Regulation S exchange offers by…
Applied Therapeutics $100 million at-the-market offering
Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by Applied Therapeutics,…